课题基金 / 基金详情

Individualized approaches to determining likelihood of ASD caseness

Individualized approaches to determining likelihood of ASD caseness
确定 ASD 病例可能性的个体化方法
批准号:
10522317
负责人:
Somer L. Bishop
金额:
$82.33万
依托单位国家:
美国
项目类别:
财政年份:
2022
资助国家:
美国
项目状态:
未结题
起止时间:
2022-07-01 至 2025-04-30

项目摘要

项目成果

Somer L. Bishop的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY Ongoing development and validation of screening and diagnostic tools has been a major focus of research in autism spectrum disorders (ASD) during the past 30 years. Diagnostic validity of several widely used tools has been established by showing that, in most cases, children with ASD score above established cut-offs, whereas children with non-ASD score below cut-offs. However, a growing body of literature indicates that sensitivity and specificity of ASD symptom measures varies significantly based on the characteristics of the study population. This means that the ability of a given tool to differentiate children with and without ASD is variable, and is affected by an individual's demographic (age, sex), developmental (cognitive ability, language level), and/or behavioral (clinically significant behavior problems) profile. The long-term goal of the proposed research is to transform screening and diagnostic practices through increased individualization of measure selection and interpretation. Phenotypic heterogeneity of youth referred for possible ASD is a well-recognized challenge that prevents one-size-fits-all assessment approaches from being validly employed. Yet, with ever-growing demands for such services, clinical and research entities increasingly rely on specified batteries to make decisions about triage and diagnosis. While use of standardized tools offers many advantages, uniform application or interpretation of specific instruments disregards the vast individual heterogeneity that is a hallmark of ASD. Thus, the field is in need of updated practices, wherein tools are selected, combined, and interpreted in the context of an individual child's presentation, with specific reference to how likely it is that scores on a given test or combination of tests will indicate ASD caseness for that child. Toward this end, the proposed secondary data analysis will identify which tools, and combinations of tools, work best for identifying ASD in sub-groups of youth with shared demographic, developmental, and/or behavioral phenotypes (e.g., in toddler girls with phrase speech vs. verbally fluent adolescent boys with clinically elevated behavior problems). We will analyze data from several widely-used ASD measures, aggregated from more than 17,500 children between the ages of 18 months and 17 years, 11 months. These youth were either clinically referred for ASD diagnostic assessment, assessed due to heightened risk for ASD or other developmental delays, or recruited for ASD-focused research projects. They were assigned a best-estimate diagnosis of ASD or non-ASD (e.g., intellectual disability, ADHD, language disorder) by expert clinicians or clinical-researchers following a comprehensive assessment. By considering the interplay between individual characteristics and instrument scores in the largest sample to date, the proposed study will move the field toward more individualized approaches for establishing ASD caseness. Findings from this study will also directly inform the development of the next generation of tools, procedures, and electronic platforms for diagnostic assessment of ASD.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Individualized approaches to determining likelihood of ASD caseness
Development of a standardized measure of social-communication abilities for children with neurodevelopmental disorders
Development of a standardized measure of social-communication abilities for children with neurodevelopmental disorders
2/2 Development of a Screening Interview for Research Studies of ASD
国内基金
海外基金
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
  • 批准号:
    JCZRQN202500010
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
  • 依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
  • 批准号:
    2025JJ70209
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
    雷芬芳
  • 依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
  • 批准号:
    --
  • 项目类别:
    面上项目
  • 资助金额:
    --
  • 批准年份:
    2024
  • 负责人:
    万荣
  • 依托单位: